Market Place
Sourcing Support
Biosynth Appoints Matt Gunnison as CEO, Kieran Murphy as Chairman
06 Nov 2024 //
BUSINESSWIRE
Biosynth Opens Cutting-Edge Facility at Lifebay in Suzhou, China
30 Oct 2024 //
BUSINESSWIRE
VIO Biosynth rebrands to Biosynth
01 May 2024 //
PRESS RELEASE
FDA GMP and Global ISO Inspections successful for Biosynth
22 Jan 2024 //
PRESS RELEASE
Biosynth to Offer Complex Chemistry Solutions at Greater Scales
19 Dec 2023 //
BUSINESSWIRE
Biosynth extends its offering to multi-kilogram GMP peptide synthesis
25 Sep 2023 //
BUSINESSWIRE
Biosynth Expands Capabilities with Acquisition of celares
11 Jul 2023 //
BUSINESSWIRE
Biosynth Further Strengthens Peptide Business with Acquisition of Cambridge
09 May 2023 //
BUSINESSWIRE
Biosynth Carbosynth Expands Peptide Offering with Acquisition of Pepscan
30 Jun 2022 //
BUSINESSWIRE
Biosynth Carbosynth Expands Life Sciences Platform; Acquires Aalto Bio Reagents
26 May 2022 //
BUSINESSWIRE
Sense, Cruinn Diagnostics Sign Distribution Agreement to Market Veros COVID-19
17 Mar 2022 //
BUSINESSWIRE
Biosynth & Shengquan acquire new plant to increase production capacities China
13 Nov 2021 //
EXPRESSPHARMA
Biosynth Carbosynth & Shengquan Acquire Factory from Kexing Biopharmaceutical
10 Nov 2021 //
CONTRACTPHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.